ASGCT 2025: Cell Therapy Abstract Highlights
Our Post-Conference Report offers an in-depth analysis and summary of the 107 cell therapy-related abstracts presented at the 2025 ASGCT Annual Meeting. This report is an essential resource for staying updated on the latest developments and innovations in the field.
Highlights include insights into:
- Therapeutic Innovation: CAR T therapies continue to dominate, with a growing interest in engineered stem cell therapies
- Target Advancements: CD19 remains the most prevalent target studied, continuing to be a popular target for in vivo CAR therapies
- Disease Breakdown: Blood cancers and solid tumors were the most common diseases investigated, with continued interest in the auto-immune disease systemic lupus erythematosus
- Abstract summaries for preclinical and clinical assets
We hope you find this report valuable and insightful and are as excited as we are to see the latest cell therapy development.
You May Also Be Interested In…
Learn More About Cell Therapy
- The Most Comprehensive Way to Search the Cell Therapy Development Landscape: Unique search ontologies based on Cell Therapy drug and trial characteristics
- Market Leading Approach to Cell Therapy Preclinical & Clinical Data Curation: Manual curation of key Cell Therapy research and development data points by Cell Therapy research scientists
- Seamlessly Integrate Commercial & Scientific Data all in One Place: Search Cell Therapy company and deal data based on their pipeline and technologies.
- Unrivalled Granularity in Reports & Analysis: Our search ontology and technology indexing enable comprehensive analysis not seen elsewhere.
What is Beacon?
Beacon is a world leading data analysis tool for preclinical and clinical trial information. With unrivalled granularity of search function, data quality, and exhaustiveness, Beacon provides timely information and gives you confidence to progress your targeted drug therapies to patients.
Learn more about how our clinical trials and drug database solutions can be tailored to your research requirements
